BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Novacea’s IPO Seeks $75M To Fund Late-Stage DN-101

Feb. 14, 2006
By Aaron Lorenzo

Black Box Warning Labels To Remain On All NSAIDs

Feb. 13, 2006
By Aaron Lorenzo

Acorda’s Second Attempt At IPO Successful: $33M

Feb. 13, 2006
By Aaron Lorenzo
Acorda Therapeutics Inc. priced a $33 million initial public offering Friday, selling 5.5 million common shares at $6 apiece. (BioWorld Today)
Read More

Acorda’s Second Attempt At IPO Successful: $33M

Feb. 13, 2006
By Aaron Lorenzo
Acorda Therapeutics Inc. priced a $33 million initial public offering Friday, selling 5.5 million common shares at $6 apiece. (BioWorld Today)
Read More

Black Box Warning Labels To Remain On All NSAIDs

Feb. 13, 2006
By Aaron Lorenzo

Entereg’s Positive Phase III Data Drive Up Adolor’s Stock

Feb. 9, 2006
By Aaron Lorenzo
Adolor Corp. unveiled positive Phase III data on Entereg (alvimopan), its partnered product for postoperative ileus, boosting shares in the company. (BioWorld Today)
Read More

Entereg’s Positive Phase III Data Drive Up Adolor’s Stock

Feb. 9, 2006
By Aaron Lorenzo
Adolor Corp. unveiled positive Phase III data on Entereg (alvimopan), its partnered product for postoperative ileus, boosting shares in the company. (BioWorld Today)
Read More

Vertex Reports Data On HCV Protease Inhibitor, Earnings

Feb. 8, 2006
By Aaron Lorenzo
Hepatitis C viral loads dropped to undetectable levels in all patients receiving for about a month an investigational drug from Vertex Pharmaceuticals Inc. (BioWorld Today)
Read More

Vertex Reports Data On HCV Protease Inhibitor, Earnings

Feb. 8, 2006
By Aaron Lorenzo
Hepatitis C viral loads dropped to undetectable levels in all patients receiving for about a month an investigational drug from Vertex Pharmaceuticals Inc. (BioWorld Today)
Read More

Bush's Proposed Budget Boosts FDA Funds In '07

Feb. 7, 2006
By Aaron Lorenzo
Previous 1 2 … 63 64 65 66 67 68 69 70 71 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 15, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing